Quick turnaround surveys
Active Awarded Last action
- Contract number
- 75F40123F19029
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $85,413
Award facts
- Contract value 100% obligated
- $85,413.18 Current and potential, with all options
- Completion date 85% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541820 Public Relations Agencies
- PSC
- B599 Special Studies/Analysis- Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $85,413 |
About this award
Westat, Inc., a prominent research and professional services firm headquartered in Rockville, Maryland, has been awarded a Blanket Purchase Agreement (BPA) call for Quick Turnaround Surveys by the Food and Drug Administration (FDA) with a ceiling value of $85,413.18. This firm fixed price contract was awarded on September 27, 2023, with an ultimate completion date of May 1, 2027, and will be performed in Silver Spring, Maryland. The award represents a call against the FDA's $70 million multiple-award BPA for Quick Turnaround Social Science Research Services, established in December 2025, which enables rapid deployment of survey-based research and data collection capabilities across the agency's various program needs.
Westat brings extensive experience in survey design, data collection, and social science research to support the FDA's regulatory mission. The company operates under the General Services Administration's OASIS+ contract as a large, established government contractor without small business set-aside designation, and maintains numerous IDIQs and BPAs across federal agencies including the CDC, CMS, NIH, and USDA. The Quick Turnaround Surveys BPA call reflects the FDA's need for flexible, responsive research services to support drug safety, medical device evaluation, and consumer health initiatives, leveraging Westat's proven capability to execute rapid-turnaround social science projects for federal health agencies.
Quick answers
Who was awarded contract 75F40123F19029?
75F40123F19029 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 27, 2023.
How much is contract 75F40123F19029 worth?
The government has obligated $85,413 on 75F40123F19029.
Is contract 75F40123F19029 an order under another contract?
Yes. 75F40123F19029 is a BPA call under GS23F0155K-75F40120A00018, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).
Was contract 75F40123F19029 competed?
The extent of competition for 75F40123F19029 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award